Quotes XTL Biopharmaceuticals Ltd. Nasdaq
Equities
XTLB
US98386D3070
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.74 USD | +6.61% | +11.84% | +171.26% |
04-30 | XTL Biopharmaceuticals Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
04-29 | Top Premarket Gainers | MT |
Quotes 5-day view
Delayed Quote Nasdaq09/05/2024 | 10/05/2024 | 13/05/2024 | 14/05/2024 | 15/05/2024 | |
---|---|---|---|---|---|
Last | 2.4 $ | 2.56 $ | 2.92 $ | 2.57 $ | 2.74 $ |
Volume | 3 148 | 8 840 | 49 555 | 24 473 | 17 684 |
Change | -2.04% | +6.67% | +14.06% | -11.99% | +6.61% |
Opening | 2.41 | 2.66 | 2.74 | 2.90 | 2.75 |
High | 2.45 | 2.66 | 2.99 | 2.92 | 2.794 |
Low | 2.40 | 2.42 | 2.73 | 2.57 | 2.645 |
Performance
1 day | +6.61% | ||
1 week | +11.84% | ||
Current month | +5.79% | ||
1 month | +2.24% | ||
3 months | +222.35% | ||
6 months | +179.59% | ||
Current year | +171.26% | ||
1 year | +124.59% | ||
3 years | -15.69% | ||
5 years | +27.32% | ||
10 years | -84.16% |
Volumes
marketsBasic data
Highs and lows
Indicators
Sector Comparison - Other Biotechnology & Medical Research
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
+6.61% | +11.84% | +171.26% | +124.59% | 14.89M | ||
+0.58% | +5.88% | +29.77% | -0.92% | 49.18B | ||
+1.10% | +2.55% | +1.00% | +22.05% | 42.11B | ||
+4.89% | +1.10% | +50.47% | -8.93% | 40.37B | ||
+0.05% | -1.80% | -5.26% | +14.59% | 28.85B | ||
+1.97% | +3.22% | +13.68% | +56.33% | 26.09B | ||
-0.33% | -3.21% | -22.99% | -28.52% | 18.71B | ||
-0.77% | +8.37% | +8.22% | +2.98% | 13.26B | ||
+1.85% | +4.71% | +32.41% | +92.47% | 12.32B | ||
-0.11% | -1.16% | -1.62% | +20.90% | 11.99B | ||
+1.08% | +4.44% | +24.01% | +27.19% | 11.97B | ||
+0.84% | +6.59% | +2.23% | -2.12% | 10.07B | ||
+3.81% | +8.92% | +36.15% | -8.72% | 7.05B | ||
+1.26% | -1.83% | +15.77% | +93.67% | 6.6B | ||
-3.85% | -7.78% | +3.51% | -36.23% | 6.59B | ||
+5.38% | +2.82% | +37.34% | +48.42% | 6.17B | ||
Average | +1.47% | +0.29% | +24.75% | +26.11% | ||
Weighted average by Cap. | +1.24% | +0.76% | +16.24% | +14.53% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
Last transactions
Date | Price | Volume | Daily volume |
---|---|---|---|
20:59:52 | 2.74 | 100 | 16,075 |
20:59:52 | 2.74 | 100 | 15,975 |
20:59:52 | 2.74 | 100 | 15,875 |
20:54:12 | 2.74 | 100 | 15,775 |
20:54:12 | 2.74 | 244 | 15,675 |
20:54:12 | 2.74 | 200 | 15,431 |
20:53:55 | 2.74 | 100 | 15,231 |
20:53:55 | 2.74 | 249 | 15,131 |
20:53:44 | 2.73 | 100 | 14,882 |
20:53:44 | 2.73 | 100 | 14,782 |
Monthly variations
Annual change
2024 | +154.43% | ||
2023 | -16.52% | ||
2022 | -56.32% | ||
2021 | -8.58% | ||
2020 | +121.17% | ||
2019 | -20.81% | ||
2018 | -24.36% | ||
2017 | -27.92% | ||
2016 | -54.99% | ||
2015 | -28.79% | ||
2014 | -31.72% | ||
2013 | -60.92% | ||
2012 | +95.26% | ||
2011 | -19.15% | ||
2010 | +379.59% | ||
2009 | +91.41% | ||
2008 | -98.20% | ||
2007 | +4.01% | ||
2006 | -64.60% | ||
2005 | -32.22% |
- Stock Market
- Equities
- XTLB Stock
- XTLB Stock
- Quotes XTL Biopharmaceuticals Ltd.